本則回應

• Ann標記此篇為：💬 含有個人意見

  理由

  此影片節錄自輝瑞執行長Albert Bourla，於2022年3月11日接受華盛頓郵報直播時的訪談片段。
  
  1. 該段談話中，Bourla並非在表達對BNT新冠疫苗與mRNA技術的疑慮，網傳「Bourla甩鍋」為斷章取義。
  Bourla指出在流感疫苗研發過程，已可看出mRNA技術的成熟
  
  閱讀更多

  不同意見

  原始影片：Albert Bourla on why mRNA technology was "counterintuitive" to producing an effective vaccine
  https://www.youtube.com/watch?v=t9_YRw7jBF4
  
  BioNTech 如何完成全球第一支 COVID-19 疫苗？——《光速計畫》書評
  https://pansci.asia/archives/348898
  
  Viral targets for vaccines against COVID-19
  https://www.nature.com/articles/s41577-020-00480-0
  
  登月任務 輝瑞執行長博爾拉第一手告白
  https://ctee.com.tw/bookstore/selection/604003.html

  Albert Bourla on why mRNA technology was "counterintuitive" to producing an effective vaccine

  https://www.youtube.com/watch?v=t9_YRw7jBF4

  “It was counterintuitive because Pfizer was mastering or let's say we had very good experience and expertise with multiple technologies that could give a vac...

  BioNTech 如何完成全球第一支 COVID-19 疫苗？——《光速計畫》書評

  https://pansci.asia/archives/348898

  作者：蔡依橙 從疫苗問世之初，BNT 疫苗需求便直線上升。圖／European Commission, 對於BNT 疫苗態度的兩極化 Pfizer / BioNTech 疫苗，在臺灣被簡稱為 BNT 疫苗。這蠻有

  Viral targets for vaccines against COVID-19

  https://www.nature.com/articles/s41577-020-00480-0

  Nature Reviews Immunology - As the world races to develop vaccines against SARS-CoV-2, Dai and Gao highlight which viral targets are best to include in a vaccine and how this impacts the induced...

  登月任務 輝瑞執行長博爾拉第一手告白 - 工商時報

  https://ctee.com.tw/bookstore/selection/604003.html

  輝瑞的員工在新冠疫情爆發的前幾年已經學到：有勇氣大膽創新，做出艱難、反直覺的決定，而且我們不只是允許他們這麼做，甚至是期待他們這麼做；追求卓越不是為了彰顯自己，而是為了服務病人。